Target Audience: This activity is designed for Nurses, PAs, Physicians, and Psychiatrists. This activity is accredited for Nurses, PAs, and Physicians.
Webinar Description: Extended-release injectable buprenorphine products are becoming available commercially and there are several formulations on the market. However there is minimal clinical experience with using these products in patients with opioid use disorder and who are experiencing precipitated withdrawal. It is essential for healthcare professionals to understand and be aware of this treatment modality for OUD to share with patients as part of treatment options. Opioids remain the leading cause of fatal overdose in the US, and highly potent synthetic opioids are the most common opioid responsible for fatal overdoses, the rate of which continues to increase. This training will present data on the current state of opioid use disorder in the US, review injectable extended release buprenorphine products as well as the use of extended-release buprenorphine products for patients using fentanyl, and discuss the possible role for these treatments.
Educational Objectives:
- Discuss the data supporting the use of long-acting injectable buprenorphine (LAI-BUP) treatment.
- Compare patient selection for LAI-BUP for Opioid Use Disorder (OUD).
- Identify special risks that fentanyl use presents and strategies for use of injectable extended-release treatments.
Continuing Education information
In support of improving patient care, American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation Statements
Physicians
American Academy of Addiction Psychiatry designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses and Nurse Practitioners
American Academy of Addiction Psychiatry is an approved provider of nursing continuing education through AAAP’s Joint Accreditation provider #4008192. This activity is approved for up to 1.5 CNE credits.
PAs
American Academy of Addiction Psychiatry has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. Approval is valid until 10/7/2029. PAs should only claim credit commensurate with the extent of their participation.